United States · FDA National Drug Code directory
tizanidine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0591-2788_5c8f8c47-4f62-4954-8135-957c967dd7cb
- Product NDC
- 0591-2788
- Form
- CAPSULE, GELATIN COATED
- Composition / generic term
- tizanidine hydrochloride
- Labeler
- Actavis Pharma, Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20120206
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 150 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (0591-2788-86) · 0591-2788-86
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →